HEALTH

Prasco enters marketing, distribution agreement with GSK

BY Allison Cerra

MASON, Ohio Prasco Labs announced Wednesday it has entered into a marketing and distribution agreement with GlaxoSmithKline.

FLONASE Nasal Spray will be the first product to be marketed under this agreement. Prasco, as GSK’s agent and on GSK’s behalf, will solicit orders for, and distribute, Fluticasone Propionate Nasal Spray to all trade classes in the United States under a GSK/Prasco label.

Fluticasone Propionate Nasal Spray is AB-rated, therapeutically equivalent and substitutable for the brand FLONASE Nasal Spray. Fluticasone Propionate is indicated for the management of the nasal symptoms of seasonal and perennial allergic and nonallergic rhinitis in adults and pediatric patients 4 years of age and older.

“We are especially proud to have established this relationship with GlaxoSmithKline, a global leader in the research-based pharmaceutical industry,” said E. Thomas Arington, Prasco CEO. “We look forward to working with GSK to provide more choices for patients in the generics market.”

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
HEALTH

Bayer Diabetes Care helps patients save money, make life easier

BY Michael Johnsen

TARRYTOWN, N.Y. Bayer Diabetes Care announced Monday the availability of the new Bayer Simple Saver Program, which offers qualified people with diabetes several ways to save on their out-of pocket costs for test strips, making testing more affordable and life with diabetes simpler.

“Bayer is launching the new Simple Saver Program to make glucose monitoring more affordable,” said Michaela Griggs, VP U.S. marketing at Bayer Diabetes Care. “Because the cost of testing supplies can become a burden during an economic climate such as this, we designed our program to offer more options to save on test strips, versus other programs available, to help alleviate this challenge and simplify life for people with diabetes. Now people can continue to test at prescribed levels with less financial worry.”

When a consumer qualifies, Bayer will pay up to $360 per year, depending upon his or her state of residence or health plan. 

The Bayer Simple Saver Program can be accessed by consumers via Web site which will be promoted through Bayer advertising, physician offices, online, through Bayer customer service and in pharmacies across the country.  Most consumers will be able to save instantly at the pharmacy counter in nearly all locations nationwide.

The program is completely free for consumers and can be used in most states, Bayer reported.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
HEALTH

Novartis Consumer Health follows homeopathic trend with Theraflu Cold Pursuit

BY Michael Johnsen

PARSIPPANY, N.J. To date, there’s only been one notable company to take its venerable homeopathic brand and extend that brand into allopathic therapies. Now there’s a company, Novartis Consumer Health, that’s taking its venerable traditional brand of cough-cold therapies and line extending it with a homeopathic offering — Theraflu Cold Pursuit.

The move signifies the arrival of homeopathy to the mass consumer and at the same time may attract a new shopper to the concept of homeopathy, as the new product will be brand-blocked alongside Novartis’ other Theraflu offerings.

Formulated with two homeopathic cough-cold ingredients, the berry-flavored Theraflu Cold Pursuit begins shipping Aug. 1.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?